{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:07:29Z","timestamp":1768554449569,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["20720220006"],"award-info":[{"award-number":["20720220006"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Open Research Fund of State Key Laboratory of Vaccines for Infectious Diseases","award":["2024SKLVDkf02"],"award-info":[{"award-number":["2024SKLVDkf02"]}]},{"name":"Research Fund of Xiang An Biomedicine Laboratory","award":["2024XAKJ0101002"],"award-info":[{"award-number":["2024XAKJ0101002"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000649"],"award-info":[{"award-number":["32000649"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82041038"],"award-info":[{"award-number":["82041038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Program on Key Research Project of China","award":["2023YFC2307800"],"award-info":[{"award-number":["2023YFC2307800"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021J02006"],"award-info":[{"award-number":["2021J02006"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Project of Xiamen City","award":["2022CXY0108"],"award-info":[{"award-number":["2022CXY0108"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01332-5","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T18:17:00Z","timestamp":1765563420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Airborne transmission-mediated delivery of a live-attenuated influenza virus vector-based intranasal COVID-19 vaccine protects Syrian hamsters against SARS-CoV-2 challenge"],"prefix":"10.1038","volume":"11","author":[{"given":"Yaode","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lunzhi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiangyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruotong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"1332_CR1","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","volume":"24","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. Lancet Infect. Dis. 24, e70\u2013e72 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1332_CR2","doi-asserted-by":"publisher","first-page":"2300740","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300740","volume":"29","author":"LM Jeworowski","year":"2024","unstructured":"Jeworowski, L. M. et al. Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023. Eurosurveillance 29, 2300740 (2024).","journal-title":"Eurosurveillance"},{"key":"1332_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41591-022-02162-x","volume":"29","author":"C Kurhade","year":"2023","unstructured":"Kurhade, C. et al. Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nat. Med. 29, 344\u2013347 (2023).","journal-title":"Nat. Med."},{"key":"1332_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aas9673","volume":"4","author":"PA Szabo","year":"2019","unstructured":"Szabo, P. A., Miron, M. & Farber, D. L. Location, location, location: Tissue resident memory T cells in mice and humans. Sci. Immunol. 4, eaas9673 (2019).","journal-title":"Sci. Immunol."},{"key":"1332_CR5","doi-asserted-by":"publisher","first-page":"957107","DOI":"10.3389\/fimmu.2022.957107","volume":"13","author":"MW Russell","year":"2022","unstructured":"Russell, M. W. & Mestecky, J. Mucosal immunity: the missing link in comprehending SARS-CoV-2 infection and transmission. Front. Immunol. 13, 957107 (2022).","journal-title":"Front. Immunol."},{"key":"1332_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","volume":"22","author":"EC Lavelle","year":"2022","unstructured":"Lavelle, E. C. & Ward, R. W. Mucosal vaccines\u2014fortifying the frontiers. Nat. Rev. Immunol. 22, 236\u2013250 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1332_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-023-01408-5","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases. Signal Transduct. Target. Ther. 8, 149 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1332_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104298","volume":"85","author":"M Madhavan","year":"2022","unstructured":"Madhavan, M. et al. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: an open-label partially-randomised ascending dose phase I trial. eBioMedicine 85, 104298 (2022).","journal-title":"eBioMedicine"},{"key":"1332_CR9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(22)00087-X","volume":"10","author":"J-X Li","year":"2022","unstructured":"Li, J.-X. et al. Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial. Lancet Respir. Med. 10, 739\u2013748 (2022).","journal-title":"Lancet Respir. Med."},{"key":"1332_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17972-1","volume":"11","author":"S Wu","year":"2020","unstructured":"Wu, S. et al. A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge. Nat. Commun. 11, 4081 (2020).","journal-title":"Nat. Commun."},{"key":"1332_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/rmv.612","volume":"19","author":"N Arnberg","year":"2009","unstructured":"Arnberg, N. Adenovirus receptors: implications for tropism, treatment and targeting. Rev. Med. Virol. 19, 165\u2013178 (2009).","journal-title":"Rev. Med. Virol."},{"key":"1332_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/embj.201387442","volume":"33","author":"M de Graaf","year":"2014","unstructured":"de Graaf, M. & Fouchier, R. A. M. Role of receptor binding specificity in influenza A virus transmission and pathogenesis. EMBO J. 33, 823\u2013841 (2014).","journal-title":"EMBO J."},{"key":"1332_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/1040841X.2010.536523","volume":"37","author":"S Ge","year":"2011","unstructured":"Ge, S. & Wang, Z. An overview of influenza A virus receptors. Crit. Rev. Microbiol. 37, 157\u2013165 (2011).","journal-title":"Crit. Rev. Microbiol."},{"key":"1332_CR14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","volume":"67","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2. Sci. Bull. 67, 1372\u20131387 (2022).","journal-title":"Sci. Bull."},{"key":"1332_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39560-9","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters. Nat. Commun. 14, 4117 (2023).","journal-title":"Nat. Commun."},{"key":"1332_CR16","doi-asserted-by":"crossref","unstructured":"Zhu, F. et al. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Respir. Med. 18, 749\u2013760 (2022).","DOI":"10.1016\/S2213-2600(22)00131-X"},{"key":"1332_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S2213-2600(23)00349-1","volume":"11","author":"F Zhu","year":"2023","unstructured":"Zhu, F. et al. Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir. Med. 11, 1075\u20131088 (2023).","journal-title":"Lancet Respir. Med."},{"key":"1332_CR18","doi-asserted-by":"crossref","unstructured":"Wang, C. C. et al. Airborne transmission of respiratory viruses. Science 373, eabd9149.","DOI":"10.1126\/science.abd9149"},{"key":"1332_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.tim.2017.09.007","volume":"26","author":"JJ Bull","year":"2018","unstructured":"Bull, J. J., Smithson, M. W. & Nuismer, S. L. Transmissible Viral Vaccines. Trends Microbiol. 26, 6\u201315 (2018).","journal-title":"Trends Microbiol."},{"key":"1332_CR20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1305","volume":"144","author":"M Marin","year":"2019","unstructured":"Marin, M., Leung, J. & Gershon, A. A. Transmission of vaccine-strain varicella-zoster virus: a systematic review. Pediatrics 144, e20191305 (2019).","journal-title":"Pediatrics"},{"key":"1332_CR21","doi-asserted-by":"publisher","first-page":"e0246690","DOI":"10.1371\/journal.pone.0246690","volume":"16","author":"G Lopez Moreno","year":"2021","unstructured":"Lopez Moreno, G., Nirmala, J., Goodell, C., Culhane, M. & Torremorell, M. Shedding and transmission of a live attenuated influenza A virus vaccine in pre-weaned pigs under field conditions. PLoS ONE 16, e0246690 (2021).","journal-title":"PLoS ONE"},{"key":"1332_CR22","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/jpids\/piz086","volume":"9","author":"J Treanor","year":"2020","unstructured":"Treanor, J. History of live, attenuated influenza vaccine. J. Pediatr. Infect. Dis. Soc. 9, S3\u2013S9 (2020).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"1332_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/d41586-022-02233-6","volume":"609","author":"H Ledford","year":"2022","unstructured":"Ledford, H. Spate of polio outbreaks worldwide puts scientists on alert. Nature 609, 20\u201321 (2022).","journal-title":"Nature"},{"key":"1332_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jim.2014.03.023","volume":"410","author":"RR Thangavel","year":"2014","unstructured":"Thangavel, R. R. & Bouvier, N. M. Animal models for influenza virus pathogenesis, transmission, and immunology. J. Immunol. Methods 410, 60\u201379 (2014).","journal-title":"J. Immunol. Methods"},{"key":"1332_CR25","doi-asserted-by":"crossref","unstructured":"Nguyen, T.-Q., Rollon, R. & Choi, Y.-K. Animal models for influenza research: strengths and weaknesses. Viruses 13, 1011 (2021).","DOI":"10.3390\/v13061011"},{"key":"1332_CR26","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/v20801530","volume":"2","author":"NM Bouvier","year":"2010","unstructured":"Bouvier, N. M. & Lowen, A. C. Animal models for influenza virus pathogenesis and transmission. Viruses 2, 1530\u20131563 (2010).","journal-title":"Viruses"},{"key":"1332_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39090-4","volume":"14","author":"CB Stauft","year":"2023","unstructured":"Stauft, C. B. et al. Intranasal or airborne transmission-mediated delivery of an attenuated SARS-CoV-2 protects Syrian hamsters against new variants. Nat. Commun. 14, 3393 (2023).","journal-title":"Nat. Commun."},{"key":"1332_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00654-6","volume":"8","author":"JM Knisely","year":"2023","unstructured":"Knisely, J. M. et al. Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities\u2014workshop report. npj Vaccines 8, 53 (2023).","journal-title":"npj Vaccines"},{"key":"1332_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/21645515.2017.1377376","volume":"14","author":"KGI Mohn","year":"2018","unstructured":"Mohn, K. G. I., Smith, I., Sjursen, H. & Cox, R. J. Immune responses after live attenuated influenza vaccination. Hum. Vaccines Immunother. 14, 571\u2013578 (2018).","journal-title":"Hum. Vaccines Immunother."},{"key":"1332_CR30","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1073\/pnas.2009799117","volume":"117","author":"M Imai","year":"2020","unstructured":"Imai, M. et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl. Acad. Sci. USA 117, 16587 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01332-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01332-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01332-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:18:28Z","timestamp":1768486708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01332-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1332"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01332-5","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}